Global University Venturing

OUP has closed an oversubscribed third fund that it expects will invest in 40 to 50 spinouts, primarily originating from 19 core partner institutions.

The accelerator will support up to 12 health projects at a time, led by innovators including UW Health faculty and with resources provided by four partners including Warf.

VC assets accounted for 19% of Yale’s endowment portfolio by June 2018 compared with 13.7% four years previously, as resources shifted away from leveraged buyouts and real estate.

Garwood Medical Devices is developing two therapeutic electrode-powered products based on licences from University of Buffalo, having last raised $3.6m in 2016.

MIT spinout Conduit was founded in 2017 to commercialise a decentralised cloud computing concept drawing upon the spare processing resources of IT clusters.

The Cambridge spinout plans to build out the business for its automated customer support platform after collecting $12m in series A funding.

Gyroscope Therapeutics recently commenced phase 1/2 clinical trials on a retinal gene therapy for dry age-related macular degeneration.

The seed capital will help UAB-founded TriAltus Bioscience commercialise its protein purification materials, which are already being used by research clients in the US, Brazil and EU.

UCSD-founded imaging technology developer Gojoya has collected cash from Intel Capital to pursue product development and recruitment.

Anaveon emerged out of University of Zurich in late 2017 with the support of Novartis-backed UZH Life Sciences Fund and the corporate has now also invested directly.

A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.